Study of ORIC-101 in Combination With Anticancer Therapy
Clinical trial NCT03928314 · TERMINATED
Trial details
- NCT number
- NCT03928314
- Sponsor
- ORIC Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-02
- Primary completion
- 2022-09-22
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.